Targeting the nasty nestin to shoot lung fibrosis

Eur Respir J. 2022 May 5;59(5):2103146. doi: 10.1183/13993003.03146-2021. Print 2022 May.

Olivier Burgy^{1

2}, Bruno Crestani^{3

4}, Philippe Bonniaud^{5

2

6}

¹ INSERM U1231, Faculty of Medicine and Pharmacy, University of Bourgogne-Franche Comté, Dijon, France olivier.burgy@u-bourgogne.fr.
² Constitutive Reference Center for Rare Pulmonary Diseases - OrphaLung, Dijon-Bourgogne University Hospital, Dijon, France.
³ Université Paris Cité, Inserm, U1152, laboratoire d'excellence INFLAMEX, Paris, France.
⁴ APHP, Service de Pneumologie A, Constitutive Reference Center for Rare Pulmonary Diseases - OrphaLung, FHU APOLLO, Hôpital Bichat, Paris, France.
⁵ INSERM U1231, Faculty of Medicine and Pharmacy, University of Bourgogne-Franche Comté, Dijon, France.
⁶ Dept of Pulmonary Medicine and Intensive Care Unit, Dijon-Bourgogne University Hospital, Dijon, France.

No abstract available

Publication types